TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2009

Multicenter study of decitabine administered daily for 5 days every 4 weeks to adults with myelodysplastic syndromes: the alternative dosing for outpatient treatment (ADOPT) trial.

David P Steensma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.